BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9446793)

  • 1. Binding of single substituted promiscuous and designer peptides to purified DRB1*0101.
    Macklin KD; Conti-Fine BM
    Biochem Biophys Res Commun; 1998 Jan; 242(2):322-6. PubMed ID: 9446793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of the allele specific Ag-binding site on murine class II MHC].
    Kajino K
    Hokkaido Igaku Zasshi; 1996 Mar; 71(2):187-203. PubMed ID: 8641675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of two tetanus toxin universal T cell epitopes in their interaction with DR1101 and DR1104 alleles.
    Valmori D; Sabbatini A; Lanzavecchia A; Corradin G; Matricardi PM
    J Immunol; 1994 Mar; 152(6):2921-9. PubMed ID: 7511633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
    Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
    J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
    Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
    J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
    May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class II HLA-peptide binding prediction using structural principles.
    Mohanapriya A; Lulu S; Kayathri R; Kangueane P
    Hum Immunol; 2009 Mar; 70(3):159-69. PubMed ID: 19187794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodominance does not result from peptide competition for MHC class II presentation.
    Lo-Man R; Langeveld JP; Martineau P; Hofnung M; Meloen RH; Leclerc C
    J Immunol; 1998 Feb; 160(4):1759-66. PubMed ID: 9469434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-binding motifs for the I-Ad MHC class II molecule: alternate pH-dependent binding behavior.
    Chaves FA; Richards KA; Torelli A; Wedekind J; Sant AJ
    Biochemistry; 2006 May; 45(20):6426-33. PubMed ID: 16700553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An HLA-binding-motif-aided peptide epitope library: a novel library design for the screening of HLA-DR4-restricted antigenic peptides recognized by CD4+T cells.
    Tana T; Kamikawaji N; Savoie CJ; Sudo T; Kinoshita Y; Sasazuki T
    J Hum Genet; 1998; 43(1):14-21. PubMed ID: 9609993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformation of MHC class II I-A(g7) is sensitive to the P9 anchor amino acid in bound peptide.
    Gardiner A; Richards KA; Sant AJ; Arneson LS
    Int Immunol; 2007 Sep; 19(9):1103-13. PubMed ID: 17855434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the dominant autoreactive T-cell epitope in spontaneous autoimmune haemolytic anaemia of the NZB mouse.
    Shen CR; Ward FJ; Devine A; Luross JA; Lowrey PA; Wraith DC; Elson CJ; Barker RN
    J Autoimmun; 2002 Mar; 18(2):149-57. PubMed ID: 11908947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting peptides bound to I-Ag7 class II histocompatibility molecules using a novel expectation-maximization alignment algorithm.
    Chang KY; Suri A; Unanue ER
    Proteomics; 2007 Feb; 7(3):367-77. PubMed ID: 17211830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
    Zinckgraf JW; Sposato M; Zielinski V; Powell D; Treanor JJ; von Hofe E
    Vaccine; 2009 Aug; 27(39):5393-401. PubMed ID: 19596415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of a protective helper T cell epitope of human influenza A virus hemagglutinin.
    Gogolák P; Simon A; Horváth A; Réthi B; Simon I; Berkics K; Rajnavölgyi E; Tóth GK
    Biochem Biophys Res Commun; 2000 Apr; 270(1):190-8. PubMed ID: 10733926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The wide diversity and complexity of peptides bound to class II MHC molecules.
    Suri A; Lovitch SB; Unanue ER
    Curr Opin Immunol; 2006 Feb; 18(1):70-7. PubMed ID: 16316750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic core amino acids of an immunodominant allopeptide are important for MHC binding and TCR recognition.
    Sitaru AG; Timmermann W; Ulrichs K; Otto C
    Hum Immunol; 2004 Aug; 65(8):817-25. PubMed ID: 15336783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Energetics and cooperativity of the hydrogen bonding and anchor interactions that bind peptides to MHC class II protein.
    McFarland BJ; Katz JF; Sant AJ; Beeson C
    J Mol Biol; 2005 Jul; 350(1):170-83. PubMed ID: 15921691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.